213 related articles for article (PubMed ID: 21136030)
41. Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.
Little M; Schipper M; Feng FY; Vineberg K; Cornwall C; Murdoch-Kinch CA; Eisbruch A
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1007-14. PubMed ID: 22056067
[TBL] [Abstract][Full Text] [Related]
42. Compensator-based intensity-modulated radiotherapy in head and neck cancer: our experience in achieving dosimetric parameters and their clinical correlation.
Nangia S; Chufal KS; Arivazhagan V; Srinivas P; Tyagi A; Ghosh D
Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):485-92. PubMed ID: 16909973
[TBL] [Abstract][Full Text] [Related]
43. Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer.
Bussels B; Maes A; Flamen P; Lambin P; Erven K; Hermans R; Nuyts S; Weltens C; Cecere S; Lesaffre E; Van den Bogaert W
Radiother Oncol; 2004 Dec; 73(3):297-306. PubMed ID: 15588874
[TBL] [Abstract][Full Text] [Related]
44. 3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing.
Wendt TG; Abbasi-Senger N; Salz H; Pinquart I; Koscielny S; Przetak SM; Wiezorek T
Radiat Oncol; 2006 Jun; 1():18. PubMed ID: 16790059
[TBL] [Abstract][Full Text] [Related]
45. Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy.
Hsiung CY; Ting HM; Huang HY; Lee CH; Huang EY; Hsu HC
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):454-61. PubMed ID: 16839707
[TBL] [Abstract][Full Text] [Related]
46. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
[TBL] [Abstract][Full Text] [Related]
47. Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy.
Hey J; Setz J; Gerlach R; Vordermark D; Gernhardt CR; Kuhnt T
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1475-80. PubMed ID: 19515505
[TBL] [Abstract][Full Text] [Related]
48. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up.
Sim C; Soong YL; Pang E; Lim C; Walker GD; Manton DJ; Reynolds EC; Wee J
Aust Dent J; 2018 Jun; 63(2):217-223. PubMed ID: 29569726
[TBL] [Abstract][Full Text] [Related]
49. A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials.
Roesink JM; Schipper M; Busschers W; Raaijmakers CP; Terhaard CH
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1006-9. PubMed ID: 15964708
[TBL] [Abstract][Full Text] [Related]
50. Prospective investigation and literature review of tolerance dose on salivary glands using quantitative salivary gland scintigraphy in the intensity-modulated radiotherapy era.
Lee SW; Kang KW; Wu HG
Head Neck; 2016 Apr; 38 Suppl 1():E1746-55. PubMed ID: 26875880
[TBL] [Abstract][Full Text] [Related]
51. Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life.
van Rij CM; Oughlane-Heemsbergen WD; Ackerstaff AH; Lamers EA; Balm AJ; Rasch CR
Radiat Oncol; 2008 Dec; 3():41. PubMed ID: 19068126
[TBL] [Abstract][Full Text] [Related]
52. Scintigraphic evaluation of long-term salivary function after bilateral whole parotid gland irradiation in radiotherapy for head and neck tumour.
Kaneko M; Shirato H; Nishioka T; Ohmori K; Takinami S; Arimoto T; Kagei K; Miyasaka K; Nakamura M
Oral Oncol; 1998 Mar; 34(2):140-6. PubMed ID: 9682778
[TBL] [Abstract][Full Text] [Related]
53. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer.
Eisbruch A; Ship JA; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Hogikyan ND; Anzai Y; Marsh LH; Ten Haken RK; Wolf GT
World J Surg; 2003 Jul; 27(7):832-7. PubMed ID: 14509515
[TBL] [Abstract][Full Text] [Related]
54. Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines.
Guerrero Urbano MT; Clark CH; Kong C; Miles E; Dearnaley DP; Harrington KJ; Nutting CM; PARSPORT Trial Management Group
Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):604-13. PubMed ID: 17706404
[TBL] [Abstract][Full Text] [Related]
55. Scintigraphic assessment of early and late parotid gland function after radiotherapy for head-and-neck cancer: a prospective study of dose-volume response relationships.
Roesink JM; Moerland MA; Hoekstra A; Van Rijk PP; Terhaard CH
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1451-60. PubMed ID: 15050323
[TBL] [Abstract][Full Text] [Related]
56. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
[TBL] [Abstract][Full Text] [Related]
57. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
58. Impact of Node Negative Target Volume Delineation on Contralateral Parotid Gland Dose Sparing Using IMRT in Head and Neck Cancer.
Magnuson WJ; Urban E; Bayliss RA; Harari PM
Technol Cancer Res Treat; 2015 Jun; 14(3):315-9. PubMed ID: 25782188
[TBL] [Abstract][Full Text] [Related]
59. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect.
Scrimger RA; Stavrev P; Parliament MB; Field C; Thompson H; Stavreva N; Fallone BG
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):178-85. PubMed ID: 15337554
[TBL] [Abstract][Full Text] [Related]
60. The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT.
Miah AB; Gulliford SL; Bhide SA; Zaidi SH; Newbold KL; Harrington KJ; Nutting CM
Radiother Oncol; 2013 Mar; 106(3):346-51. PubMed ID: 23540553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
